TITLE

Patterns of herpes simplex virus shedding over 1 month and the impact of acyclovir and HIV in HSV-2-seropositive women in Tanzania

AUTHOR(S)
Tanton, Clare; Weiss, Helen A; LeGoff, Jerome; Changalucha, John; Clayton, Tim C; Ross, David A; Belec, Laurent; Hayes, Richard J; Watson-Jones, Deborah
PUB. DATE
August 2011
SOURCE
Sexually Transmitted Infections;Aug2011, Vol. 87 Issue 5, p406
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Objectives: Few studies have examined the frequency and duration of genital herpes simplex virus (HSV) shedding in sub-Saharan Africa. This study describes HSV shedding patterns among a sample of HSV-2-seropositive women enrolled in a placebo-controlled trial of HSV suppressive therapy (acyclovir 400 mg twice a day) in Tanzania.Methods: Trial participants were invited to participate in a substudy involving 12 clinic visits over 4 weeks. At each visit, cervical, vaginal and external skin swabs were taken and analysed for HSV DNA using inhouse real-time PCR.Results: HSV shedding was mainly subclinical (90%; 57/63 shedding days in the placebo arm). The most frequent shedding site was the external skin, but HSV DNA was detected from all three sites on 42% (27/63) of shedding days. In HIV-negative women, HSV DNA was detected on 3% (9/275) of days in the acyclovir versus 11% (33/309) in the placebo arm, while in HIV-positive women, detection was on 14% (23/160) versus 19% (30/155) of days, respectively.Conclusions: HSV shedding was common, varying greatly by individual. Shedding rates were similar to studies in African and non-African settings. Among HIV-negative women, shedding rates were lower in the acyclovir arm; however, acyclovir did not substantially impact on HSV shedding in HIV-positive women.
ACCESSION #
64838719

 

Related Articles

  • Recurrent antiviral-resistant genital herpes in an immunocompetent patient. Kriesel, John D.; Spruance, Spotswood L.; Prichard, Mark; Parker, Jacqueline N.; Kern, Earl R. // Journal of Infectious Diseases;7/1/2005, Vol. 192 Issue 1, p156 

    Herpes simplex virus type 2 (HSV-2) resistance to antiviral drugs has been described primarily in immunocompromised patients. We report an apparently immunocompetent, human immunodeficiency virus-negative male patient who has experienced repeated HSV-2 genital outbreaks despite receiving...

  • Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2. Fisman, D.N.; Hook III, E.W.; Goldie, S.J.; Hook, E W 3rd // Sexually Transmitted Infections;Feb2003, Vol. 79 Issue 1, p45 

    Objectives: Herpes simplex virus type 2 (HSV-2) is the most common cause of ulcerative genital disease in the United States, but infection is commonly unrecognised. Serological screening tests could identify discordantly infected couples and permit targeted interventions to limit...

  • Independent Nurse: Clinical - Sexual health - Controlling genital herpes - Infection. Bickford, Jane // GP: General Practitioner;1/20/2006, p104 

    The article presents information about genital herpes. Human herpes simplex virus is the most common cause of genital ulceration in Great Britain. In countries where HIV is more common, genital ulcerative disease is an important factor to consider with respect to HIV transmission. Genital herpes...

  • Two-Day Regimen of Acyclovir for Treatment of Recurrent Genital Herpes Simplex Virus Type 2 Infection. Wald, Anna; Carrell, David; Remington, Michael; Kexel, Elizabeth; Zeh, Judy; Corey, Lawrence // Clinical Infectious Diseases;4/1/2002, Vol. 34 Issue 7, p944 

    The standard course of antiviral therapy for recurrent genital herpes requires administration of multiple doses of medication for 5 days. To assess the efficacy of a shorter course of antiviral therapy, patients with recurrent genital herpes simplex virus type 2 (HSV-2) infection were enrolled...

  • Impact of Acyclovir on Genital and Plasma HIV-1 RNA, Genital Herpes Simplex Virus Type 2 DNA, and Ulcer Healing among HIV-1-Infected African Women with Herpes Ulcers: A Randomized Placebo-Controlled Trial. Mayaud, Philippe; LeGoff, Jérôme; Weiss, Helen A.; Grésenguet, Gérard; Nzambi, Khonde; Bouhlal, Hicham; Frost, Eric; Pépin, Jacques; Malkin, Jean-Elie; Hayes, Richard J.; Mabey, David C. W.; Bélec, Laurent // Journal of Infectious Diseases;7/15/2009, Vol. 200 Issue 2, p216 

    Background. Little is known about the impact of episodic treatment of herpes on human immunodeficiency virus type 1 (HIV-1). Methods. Women from Ghana and the Central African Republic who had genital ulcers were enrolled in a randomized, double-blind, placebo-controlled trial of acyclovir plus...

  • Does acyclovir help herpes simplex virus cold sores if treatment is delayed? Madisgosky, Wendy S.; Meadows, Susan // Journal of Family Practice;Nov2004, Vol. 53 Issue 11, p923 

    Cold sores, or herpes labialis, are caused by herpes simplex virus (HSV). Recurrent lesions progress quickly through several stages. Because of the rapid development of the vesicle stage and the rapid decrease in detectable virus after 48 hours, studies of antiviral therapy empirically require...

  • Introduction. Whitley, Richard // Journal of Infectious Diseases;10/16/2002 Supplement, Vol. 186, pS1 

    Discusses the efficacy of acyclovir and valacyclovir in the treatment of herpesvirus infections. Advantages of valacyclovir therapy in herpes zoster and herpes simplex virus treatment; Management of cytomegalovirus (CMV) infections; Implication of genital herpes infection on public health;...

  • Disseminated neonatal herpes simplex virus (HSV) type 2 infection diagnosed by HSV DNA detection in blood and successfully managed by liver transplantation. Twagira, Mary; Hadzic, Nedim; Smith, Melvyn; Ramaswamy, Meghna; Verma, Anita; Dhawan, Anil; Knisely, A. S.; Mieli-Vergani, Giorgina; Geretti, Maria; Geretti, Anna Maria // European Journal of Pediatrics;2004, Vol. 163 Issue 3, p166 

    Unlabelled: We report a case of neonatal herpes presenting with liver failure and disseminated coagulopathy which followed unrecognised maternal primary genital herpes and was diagnosed by herpes simplex virus DNA detection in blood by polymerase chain reaction 2 weeks after...

  • Efficacy and Safety of Valacyclovir for the Suppression and Episodic Treatment of Herpes Simplex Virus in Patients with HIV. Warren, Terri; Harris, Julia; Brennan, Clare A. // Clinical Infectious Diseases;10/15/2004 Supplement, Vol. 39, pS258 

    The prevalence and predisposing factors of thrombotic microangiopathy (TMA) in the era of highly active antiretroviral therapy (HAART) were evaluated among patients in the Collaborations in Human Immunodeficiency Virus (HIV) Outcomes Research/US cohort. Of 6022 patients, 17 (0.3%) had TMA, with...

  • Possible reasons for an increase in the proportion of genital ulcers due to herpes simplex virus from a cohort of female bar workers in Tanzania. Riedner, Gabriele; Todd, Jim; Rusizoka, Mary; Mmbando, Donan; Maboko, Leonard; Lyamuya, Eligius; Hoffmann, Oliver; Maclean, I.; Grosskurth, Heiner; Hayes, Richard // Sexually Transmitted Infections;Apr2007, Vol. 83 Issue 2, p91 

    Objectives: To determine trends in the prevalence and aetiological distribution of genital ulcer syndrome (GUS) in a cohort of female bar workers and to assess factors associated with these trends.Methods: An open cohort of 600 women at high risk of HIV and sexually...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics